Difference between revisions of "Programmed cell death 1"
Jump to navigation
Jump to search
| Line 4: | Line 4: | ||
It binds with [[programmed death-ligand 1]] (dealt with separately) and ''programmed death-ligand 2''. | It binds with [[programmed death-ligand 1]] (dealt with separately) and ''programmed death-ligand 2''. | ||
==Drugs== | |||
*Pembrolizumab. | |||
*Nivolumab. | |||
*Pidilizumab. | |||
==See also== | ==See also== | ||
Revision as of 17:14, 11 May 2016
Programmed cell death 1, abbreviated PDCD1 and PD1,[1] is a protein (and gene) with an important role in immune system regulation and cancer.
It is also known as CD279.
It binds with programmed death-ligand 1 (dealt with separately) and programmed death-ligand 2.
Drugs
- Pembrolizumab.
- Nivolumab.
- Pidilizumab.
See also
- Programmed death-ligand 1 (PD-L1).